CN117222326A - Novel palatability enhancing compositions - Google Patents
Novel palatability enhancing compositions Download PDFInfo
- Publication number
- CN117222326A CN117222326A CN202280031585.6A CN202280031585A CN117222326A CN 117222326 A CN117222326 A CN 117222326A CN 202280031585 A CN202280031585 A CN 202280031585A CN 117222326 A CN117222326 A CN 117222326A
- Authority
- CN
- China
- Prior art keywords
- phase
- pet food
- palatability
- trisodium pyrophosphate
- palatability enhancing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000019629 palatability Nutrition 0.000 title claims abstract description 111
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 90
- MLIKYFGFHUYZAL-UHFFFAOYSA-K trisodium;hydron;phosphonato phosphate Chemical compound [Na+].[Na+].[Na+].OP([O-])(=O)OP([O-])([O-])=O MLIKYFGFHUYZAL-UHFFFAOYSA-K 0.000 claims abstract description 92
- 150000004682 monohydrates Chemical class 0.000 claims abstract description 56
- 235000013305 food Nutrition 0.000 claims description 131
- 238000000034 method Methods 0.000 claims description 52
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 14
- 239000003925 fat Substances 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 239000011248 coating agent Substances 0.000 claims description 7
- 238000000576 coating method Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 7
- 150000008163 sugars Chemical class 0.000 claims description 6
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 241000282326 Felis catus Species 0.000 description 19
- 239000003531 protein hydrolysate Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 14
- 108010009736 Protein Hydrolysates Proteins 0.000 description 13
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 235000021120 animal protein Nutrition 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 235000013372 meat Nutrition 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- -1 trisodium pyrophosphate compound Chemical class 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000012041 food component Nutrition 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000000634 powder X-ray diffraction Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 3
- 108010027322 single cell proteins Proteins 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- XOFFIPPBMPVZBY-UHFFFAOYSA-K trisodium;[hydroxy(oxido)phosphoryl] phosphate;hydrate Chemical compound O.[Na+].[Na+].[Na+].OP([O-])(=O)OP([O-])([O-])=O XOFFIPPBMPVZBY-UHFFFAOYSA-K 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108010066207 Poultry Proteins Proteins 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000028043 self proteolysis Effects 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 1
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- ILRYLPWNYFXEMH-WHFBIAKZSA-N L-cystathionine Chemical compound [O-]C(=O)[C@@H]([NH3+])CCSC[C@H]([NH3+])C([O-])=O ILRYLPWNYFXEMH-WHFBIAKZSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000282339 Mustela Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 238000003991 Rietveld refinement Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000012926 crystallographic analysis Methods 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 229940038485 disodium pyrophosphate Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Fodder In General (AREA)
Abstract
The present invention relates to a palatability enhancing composition comprising at least one trisodium pyrophosphate comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1.
Description
Technical Field
The present invention relates to the field of pet foods.
More precisely, the present invention relates to a palatability enhancing composition comprising at least one trisodium pyrophosphate comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1.
Background
The pet is carefully attended by the owner who provides them with the appropriate food options. These foods include not only the usual nutritionally balanced diet of pets, but also supplements, treats and toys. Pets, like humans, are attracted to foods that they consider palatable and consume more often and more easily.
For this reason, palatability enhancing compositions play a key role in improving the stimulation of the taste and/or olfactory system of animals. The powdered or liquid palatability enhancing composition provides the pet food with a pet-attractive aroma and taste. These palatability enhancing compositions are typically coated onto kibble (or other dry pet food) to allow the animal's nose and tongue to come into contact as much as possible. The palatability enhancing compositions may also be added by inclusion in kibbles, which are also often added to semi-moist pet foods or even canned pet foods.
Almost all palatability-enhancing compositions intended for cats today comprise an inorganic phosphate compound. In fact, it has been demonstrated to a large extent that inorganic phosphate compounds can very significantly enhance the palatability of foods to cats. For example, disodium pyrophosphate (US 5 186 964), trisodium pyrophosphate (US 7 186 437) and tetrasodium pyrophosphate or tetrapotassium pyrophosphate (US 6 254 920;US 6 350 485;US2005/0037108) are commonly used for this purpose.
Structurally, trisodium pyrophosphate (Na 3 HP 2 O 7 ) Consists of two different phases, namely an amorphous phase, corresponding to a phase in which the molecules are not aligned, and a crystalline phase, corresponding to a phase in which the molecules are aligned in a completely three-dimensional manner. The crystallographic analysis allows to study precisely the content of the crystalline phases, in particular to distinguish anhydrous trisodium pyrophosphate from trisodium pyrophosphate monohydrate.
To date, two forms of trisodium pyrophosphate compounds have been commercialized and used in palatability enhancing compositions intended for consumption by cats, having varying amounts of structural water in the crystalline phase: anhydrous trisodium pyrophosphate (Na) 3 HP 2 O 7 ) And trisodium pyrophosphate monohydrate (Na 3 HP 2 O 7 ·H 2 O). These two general usesIs composed of only one phase, the anhydrous phase or the monohydrate phase, respectively.
The inventor proves for the first time that the following trisodium pyrophosphate compound is selected to significantly improve palatability performance of pets: the trisodium pyrophosphate compound comprises a crystalline phase consisting of a mixture of a monohydrate phase and an anhydrous phase in very specific proportions.
Disclosure of Invention
In a first aspect, the present invention relates to a palatability enhancing composition comprising at least one trisodium pyrophosphate comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1.
In another aspect, the invention relates to a pet food product comprising the palatability enhancing composition according to the invention.
Another aspect of the invention relates to a method for preparing the palatability enhancing composition.
Another aspect of the invention relates to a method for enhancing the palatability of a pet food.
Another aspect of the invention relates to a method for producing a pet food.
Another aspect of the invention relates to the use of at least one trisodium pyrophosphate comprising a crystalline phase for enhancing the palatability of a pet food, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1.
Detailed Description
General definition
Unless otherwise specifically indicated, percentages herein are expressed by weight of the product involved. In the present invention, ranges are expressed in shorthand to avoid lengthy listing and description of each value and each value within the range. Any suitable value within the range may be selected as the upper, lower, or end value of the range where appropriate. For example, ranges 0.1 to 1.0 represent the end values of 0.1 and 1.0, intermediate values of 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, and all intermediate ranges contained within 0.1 to 1.0, such as 0.2 to 0.5, 0.2 to 0.8, 0.7 to 1.0, and the like.
Depending on the embodiment, upper or lower values or ranges of values are disclosed herein. It must be understood that any lower limit value disclosed for an entity in one embodiment may be combined with any upper limit value disclosed for the same entity in another embodiment to obtain one or more other embodiments each defined by one or more numerical ranges. In other words, when in certain embodiments one or more upper values are disclosed for an entity, and in other embodiments one or more lower values are further disclosed for the same entity, any range of values from the one or more lower values to the one or more upper values for the entity is also explicitly and explicitly disclosed herein.
As used throughout, the singular forms of words include the plural forms and vice versa, unless the context clearly dictates otherwise. Thus, references to "a," "an," and "the" generally include plural forms of each term. For example, reference to "a method" includes a plurality of such "methods". Similarly, the words "comprise", "comprising" and "include" are to be interpreted non-exclusively. Also, the terms "comprising," "having," and "or" are to be construed as non-exclusive. However, all of these terms must be considered to cover exclusive embodiments that may also be referred to using words such as "consisting of … …".
The methods and compositions exemplified herein, as well as other embodiments, are not limited to the particular methods, protocols, and reagents described herein, as these may vary as will be appreciated by those of skill in the art.
Unless clearly defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art of chemistry, biochemistry, cell biology, molecular biology and agronomy.
The term "about" as used herein in reference to a measurable value, such as an amount, duration, etc., is intended to include a variation of + -20%, more preferably + -10%, even more preferably + -5% of the specified value, as such variation is suitable for reproducing the disclosed methods and products.
"pet" means any domesticated animal, including but not limited to cats, dogs, rabbits, guinea pigs, ferrets, hamsters, mice, gerbils, birds, horses, cattle, goats, sheep, donkeys, pigs, certain fish, and the like. In the context of the present invention, preferred pets are, for example, dogs and cats, and even more particularly cats. However, while the present disclosure is directed primarily to cats, the invention is also applicable to other classes of companion animals. If desired, the present invention can be tested to assess whether it is suitable for use with different classes of animals that can be considered companion animals.
In the following description, embodiments may be employed alone or in appropriate combination by those skilled in the art.
Palatability enhancing compositions
The inventors have shown for the first time that the selection of a particular trisodium pyrophosphate having particular physicochemical characteristics provides a significant gain in enhancing the palatability of pet foods containing it. Notably, the palatability of the pet food is enhanced even further when the anhydrous phase and the monohydrate phase coexist in a particular ratio in the crystalline phase of trisodium pyrophosphate. Pet foods containing such trisodium pyrophosphate are favored over pet foods containing standard trisodium pyrophosphate, which typically form only one phase, i.e., a monohydrate phase or an anhydrous phase, in the crystalline phase.
In a first aspect, the present invention relates to a palatability enhancing composition comprising at least one trisodium pyrophosphate comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1 (based on the total weight of the crystalline phase).
Trisodium pyrophosphate comprises a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase to anhydrous phase being between 1:50 and 4:1 (based on the total weight of the crystalline phase), such trisodium pyrophosphate being referred to herein as "trisodium pyrophosphate as defined in the present invention".
As used herein, the term "palatability" refers to the overall willingness of a pet to eat and be satisfied with a certain pet food. For example, whenever a pet exhibits a preference for one of two or more pet foods, the preferred pet food is more "palatable" and has "enhanced palatability". There are different methods to evaluate palatability. Examples of such methods include exposing the pet to pet food simultaneously (e.g., side-by-side, free-choice comparison, as in a so-called "two-bowl" test, by measuring the relative consumption of at least two different pet foods), or sequentially (e.g., using a single-bowl test method). It can advantageously be determined by at least a "two bowl test" or a "comparative test" in which the animal has equal access to both compositions. Advantageously, a panel of pet owners is used to ensure a repeatable and accurate measurement of the palatability properties of pet foods.
The present invention is therefore more particularly directed to a palatability enhancing composition for pets, particularly cats.
The inventors have surprisingly shown that the crystalline monohydrate phase and crystalline anhydrous phase of trisodium pyrophosphate as defined herein must be in a monohydrate phase/anhydrous phase weight ratio (based on the total weight of the crystalline phase) of between 1:50 and 4:1 to enhance the palatability of the food product to animals, especially cats.
In particular embodiments, the crystalline monohydrate phase and crystalline anhydrous phase of trisodium pyrophosphate defined herein have a monohydrate phase/anhydrous phase weight ratio of at least 1:40, or at least 1:30, or at least 1:20, or at least 1:19 (based on the total weight of the crystalline phases).
In a particular embodiment, the crystalline monohydrate phase and crystalline anhydrous phase of trisodium pyrophosphate defined herein have a monohydrate/anhydrous phase weight ratio of less than 3:1 (based on the total weight of the crystalline phases).
In particular embodiments, the crystalline monohydrate phase and crystalline anhydrous phase of trisodium pyrophosphate defined herein have a monohydrate phase/anhydrous phase weight ratio of between 1:40 and 4:1, or between 1:30 and 4:1, or between 1:20 and 3:1, or between 1:19 and 3:1 (based on the total weight of the crystalline phases).
In particular embodiments, the crystalline phase of trisodium pyrophosphate as defined herein comprises at least 20 wt%, or at least 25 wt%, or at least 30 wt% of the anhydrous phase (% based on the total weight of the crystalline phase).
In particular embodiments, the crystalline phase of trisodium pyrophosphate as defined herein comprises less than 98 wt%, or less than 97 wt%, or less than 95 wt% of the anhydrous phase (% based on the total weight of the crystalline phase).
In particular embodiments, trisodium pyrophosphate as defined herein comprises at least 15 wt%, or at least 18 wt%, or at least 20 wt% of the anhydrous phase (% based on the total weight of the trisodium pyrophosphate).
In particular embodiments, trisodium pyrophosphate as defined herein comprises less than 95 wt%, or less than 90 wt%, or less than 80 wt%, or less than 70 wt% of the anhydrous phase (% based on the total weight of the trisodium pyrophosphate).
In particular embodiments, the crystalline phase of trisodium pyrophosphate as defined herein comprises at least 2 wt%, or at least 3 wt%, or at least 5 wt% of the monohydrate phase (% based on the total weight of the crystalline phase).
In particular embodiments, the crystalline phase of trisodium pyrophosphate as defined herein comprises less than 80 wt%, or less than 75 wt%, or less than 70 wt% of the monohydrate phase (% based on the total weight of the crystalline phase).
In particular embodiments, trisodium pyrophosphate as defined herein comprises at least 1.5 wt%, or at least 2 wt%, or at least 3 wt%, or at least 5 wt% of the monohydrate phase (% based on the total weight of the trisodium pyrophosphate).
In particular embodiments, trisodium pyrophosphate as defined herein comprises less than 80% by weight, or less than 75% by weight, or less than 70% by weight of the monohydrate phase (% based on the total weight of the trisodium pyrophosphate).
The trisodium pyrophosphate as defined in the present invention preferably contains at least 80 wt. -%, more preferably at least 82 wt. -%, more preferably at least 83 wt. -%, more preferably at least 84 wt. -%, more preferably at least 85 wt. -% of the crystalline phase according to the present invention (% being based on the total weight of the trisodium pyrophosphate).
In particular embodiments, trisodium pyrophosphate as defined herein comprises less than 99% by weight, or less than 98% by weight, or less than 97% by weight, or less than 95% by weight of the crystalline phase (% based on the total weight of the trisodium pyrophosphate).
Typically, trisodium pyrophosphate as defined herein also contains an amorphous phase (and thus is composed of two phases: a crystalline phase and an amorphous phase). The crystalline phase differs from the amorphous phase in the physical arrangement of the particles, which form a repeating pattern in the crystalline phase and are not arranged at all in the amorphous phase.
In particular embodiments, trisodium pyrophosphate as defined herein comprises at least 1%, or at least 2%, or at least 3%, or at least 4%, or at least 5% by weight of the amorphous phase (% based on the total weight of the trisodium pyrophosphate).
In particular embodiments, trisodium pyrophosphate as defined herein comprises less than 20% by weight or less than 15% by weight of the amorphous phase (% based on the total weight of the trisodium pyrophosphate).
The identification of the physical properties of trisodium pyrophosphate can be determined using a variety of analytical methods. X-ray diffractometers can be used to identify the crystalline phase. By using the conventional Rietveld refinement method, the height of the lines on the X-ray diffraction pattern can be used to determine the amount of crystalline phase (more precisely, anhydrous phase, monohydrate, etc.), and thus the amount of amorphous phase.
Trisodium pyrophosphate as defined in the present invention is usually prepared in powder form.
According to this embodiment, it is also preferred that the trisodium pyrophosphate as defined in the present invention contains particles in powder form, said particles having a particle size of less than 300 μm, preferably between 2 μm and 300 μm. It will be appreciated that with respect to the preferred particle sizes as given above, at least 80 wt%, preferably at least 90 wt%, more preferably at least 95 wt% and most preferably at least 98 wt% of the particles have the specified size. The palatability enhancing compositions of the invention may be liquid or dry.
In particular embodiments, the palatability enhancing compositions of the invention are liquid. By "liquid" is herein understood a water content of at least about 40%, preferably at least about 50%, preferably at least about 60%, preferably at least about 65%, preferably at least about 70%, preferably at least about 75%, preferably at least about 80% by weight of the palatability enhancing composition.
In another particular embodiment, the palatability enhancing composition of the invention is dry. By "dry" is herein understood a water content of less than or equal to about 10%, preferably from about 1% to about 8%, by weight of the palatability enhancing composition.
In particular embodiments, the palatability enhancing compositions of the invention comprise at least about 2% by weight, more preferably at least about 3% by weight, more preferably at least about 4% by weight, more preferably at least about 5% by weight, more preferably at least about 6% by weight, more preferably at least about 7% by weight, more preferably at least about 8% by weight, more preferably at least about 10% by weight of trisodium pyrophosphate as defined herein (% based on the total weight of the palatability enhancing composition). Preferably, the palatability enhancing composition of the invention comprises up to about 50% by weight, more preferably up to about 40% by weight, more preferably up to about 30% by weight of trisodium pyrophosphate as defined herein (% based on the total weight of the palatability enhancing composition).
The palatability enhancing compositions of the invention may further comprise at least one additional ingredient. Preferably, the at least one additional ingredient further enhances palatability and is for example selected from the group consisting of protein hydrolysates, amino acids, sugars, fats and yeasts.
The "protein hydrolysate" is made from all conventional protein sources suitable for animal consumption, in particular vegetable protein sources (such as vegetables, roots, tubers, stems, grains) (hereinafter referred to as "vegetable protein hydrolysate"), animal protein sources (such as poultry, pork, beef, mutton, lamb, milk, egg) (hereinafter referred to as "animal protein hydrolysate"), marine protein sources (hereinafter referred to as "marine protein hydrolysate"), and single cell protein sources (such as algae, bacteria, yeast) (hereinafter referred to as "single cell protein hydrolysate"). The protein source has been hydrolysed chemically and/or enzymatically, for example by proteases or by lipases, or by autolysis.
"sugar" includes monosaccharides, disaccharides or oligosaccharides (including hydrolysis products of disaccharides and/or oligosaccharides), more particularly reducing sugars that can provide free or available carbonyl groups. These reducing sugars may be involved in maillard reactions with amino acids or peptides. Examples of reducing sugars include xylose, arabinose, ribose, glucose, fructose, mannose, galactose, rhamnose, lactose, maltose, raffinose.
The term "yeast" herein refers to any yeast (preferably inactive), as well as yeast by-products that are compatible with the animal food composition. Yeasts include, but are not limited to, saccharomyces cerevisiae, molasses yeast, and the like. Yeast by-products include, but are not limited to, yeast extracts, yeast hydrolysates, yeast milk, yeast autolysates, and the like.
The term "amino acid" refers to a free amino acid, i.e., an amino acid that exists alone in the composition as an unbound component, or an amino acid that results from hydrolysis/autolysis of a starting material. The free amino acids do not form part of or are not comprised in the peptide or protein and are not linked to other amino acids by peptide bonds. Intermediates, degradation products or homologs of amino acids (e.g., homocysteine, cystathionine, cysteamine, etc.) are preferably also included in the term "amino acid".
Examples of fats include animal fat (tall), oils of any origin such as animal oil (e.g., poultry fat, chicken fat, pork fat, milk-derived fat, tallow, or mutton fat, etc., and by-products thereof), vegetable oils (including vegetable oils), or marine oils.
In particular embodiments, the palatability enhancing compositions of the present invention further comprise at least one protein hydrolysate, such as a plant protein hydrolysate, an animal protein hydrolysate, a marine protein hydrolysate, or a single cell protein hydrolysate. In a preferred embodiment, the palatability enhancing composition of the invention further comprises at least one animal protein hydrolysate, such as poultry protein hydrolysate or pork protein hydrolysate.
In a particular embodiment, the palatability enhancing composition of the invention consists of at least one trisodium pyrophosphate as defined in the present invention.
Methods for preparing palatability enhancing compositions
Another aspect of the invention relates to a method for preparing a palatability enhancing composition comprising:
a) Providing at least one trisodium pyrophosphate as defined herein;
b) Providing one or more additional ingredients, preferably at least a protein source, amino acids, sugars, fats and yeast;
c) Optionally hydrolyzing the one or more additional ingredients;
d) Adding the at least one trisodium pyrophosphate to the one or more additional ingredients, thereby obtaining the palatability enhancing composition.
In a particular embodiment, the method comprises a step a 1) prior to step a), said step a 1) comprising preparing said at least one trisodium pyrophosphate as defined in the present invention. There is no particular limitation on this method for preparing trisodium pyrophosphate as defined in the present invention, as long as a crystalline monohydrate phase and a crystalline anhydrous phase can be obtained at a monohydrate phase/anhydrous phase weight ratio of between 1:50 and 4:1.
For example, to obtain the particular physicochemical characteristics of trisodium pyrophosphate described herein, the ratio of the anhydrous crystalline phase and the monohydrate crystalline phase may be controlled by varying the process used to prepare trisodium pyrophosphate and/or the method used to store trisodium pyrophosphate. For example, storage temperature and/or humidity and/or storage time may affect these ratios. Those skilled in the art can readily monitor the crystal phase ratio using the techniques disclosed above, particularly X-ray diffraction methods.
In a preferred embodiment, at least one protein source is provided in step b). In a preferred embodiment, at least one animal protein hydrolysate, such as poultry protein hydrolysate or pork protein hydrolysate, is provided in step b).
Preferably, step c) (hydrolysis) is performed. The step c) may comprise the step of contacting the ingredients with at least one enzyme and allowing the enzyme to hydrolyze the one or more additional ingredients. In these cases, the one or more additional ingredients include at least a protein source and/or fat, more preferably at least a protein source.
For example, hydrolysis is carried out at a temperature in the range of about 50 ℃ to about 200 ℃. For example, hydrolysis may be carried out for a period of time ranging from about 5 minutes to about 5 hours. These parameters are applicable under standard atmospheric conditions of temperature and pressure. However, one skilled in the art can adjust these parameters under other conditions.
The enzymes used in this hydrolysis step c) may be proteases and/or lipases. Preferably, at least a protease is used.
Of course, other additional ingredients may be added before and/or after the hydrolysis step c), such as nutrients (e.g. vitamins, minerals, electrolytes), antioxidants, preservatives, texturizing agents (e.g. xanthan gum, alginate, carrageenan, guar gum, gum arabic) and/or carriers (e.g. maltodextrin).
The above method may comprise the additional step of drying the palatability enhancing composition after step c) or step d). The drying step is a routine task for a person skilled in the art. Typically, drying is performed to remove any excess water. In particular, the resulting water content is less than or equal to about 10%, preferably from about 1% to about 8%, by weight of the palatability-enhancing composition thus obtained.
In one embodiment, the method as described above comprises the following additional steps after step b) or step c):
c1 Combining one or more additional ingredients produced in step b) or c) with a carrier (e.g. maltodextrin) in suitable proportions; and/or
c2 Drying the resulting product, for example by evaporation, at a suitable temperature, thereby obtaining a dried composition to which trisodium pyrophosphate as defined in the present invention may be added in step d).
In a particular embodiment, the at least one trisodium pyrophosphate as defined in the present invention is incorporated in step d) in an amount of at least about 2%, more preferably at least about 3%, more preferably at least about 4%, more preferably at least about 5%, more preferably at least 6%, more preferably at least about 7%, more preferably at least about 8%, more preferably at least about 10% (% based on the total weight of the palatability-enhancing composition) and/or at most about 50%, more preferably at most about 40%, more preferably at most about 30% (% based on the total weight of the palatability-enhancing composition).
Those skilled in the art will be able to select the appropriate steps, adjust the steps as necessary, select the appropriate order in which to perform the selected steps, and it is known that certain steps may be performed simultaneously in accordance with common practice in the art.
One object of the present invention relates to a palatability-enhancing composition obtained by the above-described method.
Pet food comprising palatability enhancing composition
Another aspect of the invention is a pet food comprising the palatability enhancing composition as described above.
The pet food may be a nutritionally balanced pet food, pet food supplement, medicament, snack, toy (chewable and/or consumable toy), drink or beverage. In particular embodiments, the pet food is a nutritionally balanced pet food.
A "nutritionally balanced" (or "nutritionally complete" or "complete and nutritionally balanced") pet food is a food that contains all known nutrients required by the intended recipient or consumer of the food in appropriate amounts and proportions according to, for example, recommendations of recognized or regulatory bodies in the field of companion animal nutrition, such as AAFCO. Thus, such pet foods can be used as the sole source of dietary intake to sustain life without the need to add supplemental nutritional sources. Food supplements, treats, toys, beverages and beverages are not included in the term "nutritionally balanced pet food". In general, there are three main categories or grades of nutritionally balanced pet food depending on the moisture content (low or medium or high):
dry pet food (having less than about 14% moisture), such as dry kibble;
semi-moist or semi-dry pet food (having about 14% to about 50% moisture);
canned or wet pet foods (having a moisture content of greater than about 50%), such as meat cakes (loaf), meat spreads (pats), mousses (mousse), etc.), X-block products (blocks in "X" formulations, such as jelly block products, gravy block products, etc.
The medicament (for pets) and pet supplement may be in any form, such as solid, liquid, gel, tablet, capsule, powder, etc. The palatability enhancing compositions are useful for improving the palatability of pharmaceuticals and pet supplements in the same manner they are used to improve the palatability of other pet foods.
In particular embodiments, the pet food is a solid pet food. A "solid pet food product" is a food product having less than about 50% moisture and may be a dry pet food product, semi-moist pet food product, pet supplement, pharmaceutical, snack or toy product, more preferably a dry pet food product, especially a dry kibble. For this particular embodiment, the palatability enhancing composition of the invention is preferably contained in a coating of a solid pet food.
In another particular embodiment, the pet food is a wet pet food, particularly an "X" block product or meat cake. Importantly, while the description herein is primarily directed to kibbles and other solid pet foods, it should be understood that the palatability enhancing compositions of the present invention can also be used with wet pet foods.
The pet food according to the present invention may comprise pet food ingredients such as proteins, peptides, amino acids, cereals, carbohydrates, fats or lipids, flavouring agents, additives. Food balance (relative proportions including vitamins, minerals, lipids, proteins and carbohydrates) is determined according to dietary standards known in the veterinary arts, for example, by following recommendations of the National Research Council (NRC) or guidelines of the american feed control society (AAFCO, american Association of Feed Control Officials).
In particular embodiments, the pet food comprises at least 0.2 wt%, at least 0.5 wt%, at least 1 wt%, at least 2 wt%, at least 3 wt%, at least 4 wt%, at least 5 wt% of the palatability enhancing composition, based on the total weight of the pet food.
The pet food may comprise less than 50 wt%, preferably less than 40 wt%, more preferably less than 30 wt%, more preferably less than 20 wt%, more preferably less than 10 wt%, more preferably less than 5 wt% of the palatability enhancing composition (% based on the total weight of the pet food).
In a particular embodiment, the amount of at least one trisodium pyrophosphate as defined herein is at least 0.01%, preferably at least 0.05%, more preferably at least 0.1% by weight of the pet food.
In a particular embodiment, the amount of at least one trisodium pyrophosphate as defined herein is less than 3%, preferably less than 2%, more preferably less than 1.5%, more preferably less than 1%, more preferably less than 0.9%, more preferably less than 0.8% by weight of the pet food.
In a particular embodiment, the amount of at least one trisodium pyrophosphate as defined herein is between 0.1% and 0.5% by weight of the pet food.
The palatability enhancing composition as described above is preferably contained in a coating of a pet food. The palatability enhancing compositions as described above may also be included in pet foods.
In one embodiment, the pet food of the present invention is a cat food.
The invention also relates to a pet food product comprising at least one trisodium pyrophosphate as defined in the present invention, more particularly comprising a crystalline phase, wherein said crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1.
Of course, the technical features listed above for trisodium pyrophosphate as defined in the present invention apply here as well as throughout the present invention.
Method for producing pet food
Another aspect of the invention relates to a method for producing a pet food (preferably a cat food), wherein the method comprises:
a) A pet food product is provided which is a pet food,
b) The palatability enhancing composition as described above is added to a pet food.
The method may comprise a step a 1) of preparing the pet food prior to step a). Pet foods can generally be prepared by different methods known to those skilled in the art.
Step b) may be performed by: the palatability enhancing compositions of the present invention are added to pet food either by coating or by inclusion therein. In a particular embodiment, step b) is performed by adding the palatability enhancing composition of the invention to a pet food by coating.
For example, a method for coating a solid pet food (such as a dry pet food, more particularly a dry kibble) may be cited. The uncoated kibble can be placed in a container, such as a tub or coating drum, for mixing. The palatability enhancing compositions of the invention may then be applied in liquid or powder form. The fat may be sprayed onto the dry kibble in advance. Alternatively, the fat and the palatability enhancing composition of the invention may be mixed and applied simultaneously.
Alternatively, the palatability enhancing compositions of the invention may be incorporated or included into a solid pet food, such as a dry pet food, more particularly a dry kibble, according to the following illustrative method. The palatability enhancing composition of the invention is typically contacted with the ingredients of the pet food formulation prior to cooking. For example, the palatability enhancing compositions of the invention are combined with proteins, fibers, carbohydrates, and/or starches, etc. in pet food formulations and cooked with these materials in a cooker-extruder.
Inclusion into wet pet food may be accomplished as follows. The palatability enhancing compositions of the invention may be applied in a gravy-type or jelly-type matrix during mixing in addition to other pet food ingredients. The palatability enhancing compositions of the present invention may also be applied to meat mixtures (means-by-mix) of chunk products or meat cake preparations. In this case, it may be added to the raw material before or after the grinding process. The meat mixture may be cooked in a steam oven or oven in the case of manufacturing a loaf-like product or directly sealed in a tank in the case of manufacturing a meat cake.
Of course, the technical features listed above for the palatability enhancing compositions and pet foods according to the invention may also be applied to the method.
Methods and uses for enhancing palatability/increasing pet food intake
Yet another aspect of the invention relates to a method for enhancing the palatability of a pet food, wherein the method comprises:
a) A pet food product is provided which is a pet food,
b) The palatability enhancing composition as described above is added to a pet food.
The present invention also relates to the use of a palatability enhancing composition as described above for enhancing the palatability of a pet food.
The invention also relates to the use of at least one trisodium pyrophosphate as defined in the present invention, more particularly comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1, for enhancing the palatability of a pet food product.
The invention also relates to the use of at least one trisodium pyrophosphate as defined in the present invention, more particularly containing a crystalline phase, wherein said crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1, as a palatability enhancer for pet food.
The invention also relates to the use of at least one trisodium pyrophosphate as defined in the present invention, more particularly comprising a crystalline phase, wherein said crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1, for the manufacture of a pet food palatability enhancing composition.
With respect to these methods and uses, the palatability of a pet food is enhanced as compared to another pet food that does not comprise a palatability enhancing composition according to the invention, and in particular does not comprise trisodium pyrophosphate as defined herein. Preferably, the pet food is cat food.
Of course, the technical features listed above for palatability enhancing compositions, pet foods, and methods for producing pet foods having enhanced palatability may also be applicable to these uses and methods.
Method for feeding pets
Another aspect of the invention relates to a method for feeding a pet (preferably a cat), the method comprising at least:
a) Providing a pet food product as described above; and
b) Feeding the pet food to a pet.
Methods and uses for increasing pet food intake
Another aspect of the invention relates to a method for increasing the intake of pet food by a pet, preferably a cat, said method comprising at least the steps of:
a) Providing a pet food product as described above; and
b) Feeding the pet food to a pet.
The present invention also relates to the use of a palatability enhancing composition as described above for increasing the intake of pet food by a pet.
The invention also relates to the use of at least one trisodium pyrophosphate as defined in the present invention, more particularly comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1, for increasing the intake of pet food by pets.
The intake of the pet food is particularly increased compared to another pet food which does not comprise the palatability enhancing composition according to the invention, in particular which does not comprise trisodium pyrophosphate as defined in the invention.
Of course, the technical features listed above for palatability enhancing compositions, pet foods, and methods for producing pet foods having enhanced palatability may also be applicable to these uses and methods.
Kit for enhancing palatability of pet food
Another aspect of the invention relates to a kit for enhancing the palatability of a pet food comprising in one or more containers in a single package at least the following components:
a) A palatability enhancing composition as described above; and
b) Optionally, at least one pet food ingredient.
Another aspect of the invention relates to a kit for preparing a palatability enhancing composition as described above comprising at least one trisodium pyrophosphate as defined in the present invention.
A particular kit according to the invention further comprises means for communicating information or instructions to aid in the use of the elements of the kit.
The following examples are intended to illustrate the invention, but are not to be construed as limiting in any way.
Examples
1. Materials and methods
1.1. Preparation of pet food products comprising palatability enhancing compositions
Six trisodium pyrophosphate compounds (hereinafter also referred to as "TPP") are provided, which are characterized in table 1 (see section 1.3 for analytical methods). Compounds A, E and F are in accordance with the invention, whereas compounds B, C and D are not.
Compound B is a commercial anhydrous trisodium pyrophosphate of the prior art, obtained shortly after its preparation.
Compound C is a commercial trisodium pyrophosphate monohydrate of the prior art, obtained shortly after its preparation.
The inventors applied controlled conditions to compound B to obtain compounds A, D, E and F. For this purpose, the storage temperature, humidity and time are carefully controlled to obtain the desired ratio (in particular the monohydrate phase/anhydrous phase weight ratio).
TABLE 1
*1 Weight based on total weight of trisodium pyrophosphate
*2 Weight based on the total weight of the crystalline phase
*3 Based on the total weight of the crystalline phase.
Palatability enhancing compositions ("PE") were prepared by mixing a trisodium pyrophosphate compound and optionally hydrolyzed animal protein (0.6 wt% of kibble). The formulation of the palatability enhancing composition is described in table 2 below. PE1 through PE6 are in accordance with the invention, while PE7 through PE14 are not.
TABLE 2
*1 Weight based on the total weight of the kibble.
These compositions were sprayed onto dry cat kibbles (coated "diet X" with "PE X") that were pre-coated with fat (6%).
1.2. Determination of palatability by a double bowl test
The test operation method comprises the following steps:
the palatability of both products was evaluated in panlis (france) using a two bowl test (two meal per day for two days) on 40 cats. The same amount of both products were weighed out and placed in the same bowl. The amount present in each ration is sufficient to meet daily requirements. Animals are not included in the statistical treatment if they have a higher or lower consumption compared to a predetermined value (which varies with, for example, the weight and/or metabolism of the animal). The final intake of each food was measured. The results are shown as relative consumption ratios of A or B or C or D.
Statistical analysis
Statistical analysis is used to determine if there is a significant difference between the two ratios. Student t-tests were performed with 3 error thresholds (i.e., 5%, 1% and 0.1%).
The significance level was recorded as follows:
ns is not significant (p > 0.05)
* Significantly (p is less than or equal to 0.05)
* Highly significant (p.ltoreq.0.01)
* Very highly significant (p.ltoreq.0.001).
1.3. Analysis of trisodium pyrophosphate microstructure
Crystal structure identification
The crystal structure of the monohydrate crystal phase is described in the literature, which can be quantified by X-ray powder diffraction methods [1].
The crystal structure of the amorphous phase has been determined by X-ray powder diffraction using a Bruker D8 apparatus using X-ray thermal diffraction measurements under a nitrogen stream and a copper radiation source. The crystal structure of the anhydrous crystal source is determined by the Dicvol 2 procedure.
Quantification of the crystalline phase
Trisodium pyrophosphate was analyzed by X-ray diffraction to quantify the amount of anhydrous and monohydrate phases. An internal standard (MgO) was used to calculate the mass ratio of each identified phase. The amounts of the anhydrous phase and the monohydrate phase were calculated from the diffraction spectrum data. The amorphous portion of the product is calculated from the difference.
2. Results
Tests were performed under different conditions (whether combined with hydrolyzed animal protein, type of animal protein source, amount of trisodium pyrophosphate (by weight of cat food)) to compare the palatability of trisodium pyrophosphate according to the present invention to trisodium pyrophosphate not according to the present invention.
In the examples herein below, the cat food product comprising trisodium pyrophosphate in accordance with the present invention in the palatability enhancing composition is an "experimental diet" and the cat food product comprising trisodium pyrophosphate in accordance with the present invention in the palatability enhancing composition is a "control diet".
2.1. Example 1
A comparative test was performed to compare the palatability of compound a according to the invention with that of compound B not according to the invention. Compound B of the prior art does not have any crystalline monohydrate phase.
The results are shown in Table 3.
TABLE 3 Table 3
These results demonstrate that the specific trisodium pyrophosphate compounds defined by the present invention (comprising both the monohydrate phase and the anhydrous phase in specific proportions) have better strengthening properties than trisodium pyrophosphate compounds of the prior art, in which the crystalline phase consists solely of the anhydrous phase.
2.2. Example 2
A comparative test was performed to compare the palatability of compound a according to the invention with that of compound C not according to the invention. Compound C of the prior art does not have any crystalline anhydrous phase.
The results are shown in Table 4.
TABLE 4 Table 4
These results demonstrate that the specific trisodium pyrophosphate compounds defined by the present invention (comprising both a monohydrate phase and an anhydrous phase in a specific ratio) have better strengthening properties than trisodium pyrophosphate compounds of the prior art, in which the crystalline phase consists of only a monohydrate phase.
2.3. Example 3
A comparative test was performed to compare the palatability of compound a according to the invention to compound D not according to the invention. Both compounds have different proportions of crystalline anhydrous and crystalline monohydrate phases.
The results are shown in Table 5.
TABLE 5
This result demonstrates that better enhancement is obtained because the trisodium pyrophosphate defined by the present invention has a specific monohydrate phase and anhydrous phase ratio.
Reference to the literature
[1]L.S.Ivashkevich,K.A.Selevich,A.S.Lyakhov,A.F.Selevich,Y.I.Petrusevich,The crystal structure of Na 3 HP 2 O 7 .H 2 O from X-ray powder diffraction data,Zeitschrift Für Kristallographie-Crystalline Materials.217(2002),73-77
[2]D.Loüer,A.Boultif,Some further considerations in powder diffraction pattern indexing with the dichotomy method,Powder Diffraction.29(2017)S7-S12。
Claims (12)
1. A palatability enhancing composition comprising at least one trisodium pyrophosphate comprising a crystalline phase, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase to anhydrous phase being between 1:50 and 4:1.
2. The palatability enhancing composition of claim 1, wherein said at least one trisodium pyrophosphate comprises at least 2% by weight and/or less than 20% by weight of an amorphous phase.
3. The palatability enhancing composition of claim 1 or 2 wherein said at least one trisodium pyrophosphate comprises at least 80% and/or less than 98% by weight of said crystalline phase.
4. The palatability enhancing composition of any one of claims 1-3 wherein said palatability enhancing composition comprises at least about 2 weight percent of said trisodium pyrophosphate.
5. A pet food comprising the palatability enhancing composition of any one of claims 1 to 4.
6. The pet food product of claim 5, wherein the amount of the at least one trisodium pyrophosphate is at least 0.01% and/or less than 2% by weight of the pet food product.
7. The pet food of claim 5 or 6 wherein the palatability enhancing composition is included in a coating of the pet food.
8. A method for preparing a palatability enhancing composition comprising:
a) Providing at least one trisodium pyrophosphate as defined in any one of claims 1 to 3;
b) Providing one or more additional ingredients, preferably selected from the group consisting of protein sources, amino acids, sugars, fats, and yeasts;
c) Optionally hydrolyzing the one or more additional ingredients;
d) Adding the at least one trisodium pyrophosphate to the one or more additional ingredients, thereby obtaining the palatability enhancing composition.
9. The method of claim 8 wherein the at least one trisodium pyrophosphate is incorporated in step d) in an amount of at least about 2% by weight of the palatability enhancing composition.
10. A method for producing a pet food, wherein the method comprises:
a) A pet food product is provided which is a pet food,
b) The addition of the palatability enhancing composition of any one of claims 1 to 4 to a pet food.
11. A method for enhancing the palatability of a pet food, wherein the method comprises:
a) A pet food product is provided which is a pet food,
b) The addition of the palatability enhancing composition of any one of claims 1 to 4 to a pet food.
12. Use of at least one trisodium pyrophosphate comprising a crystalline phase for enhancing the palatability of a pet food, wherein the crystalline phase comprises a monohydrate phase and an anhydrous phase, the weight ratio of monohydrate phase/anhydrous phase being between 1:50 and 4:1.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21305564.3 | 2021-04-30 | ||
EP21305564 | 2021-04-30 | ||
PCT/EP2022/061531 WO2022229411A1 (en) | 2021-04-30 | 2022-04-29 | Novel palatability-enhancing composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117222326A true CN117222326A (en) | 2023-12-12 |
Family
ID=75904844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202280031585.6A Pending CN117222326A (en) | 2021-04-30 | 2022-04-29 | Novel palatability enhancing compositions |
Country Status (7)
Country | Link |
---|---|
US (1) | US20240206498A1 (en) |
EP (1) | EP4329512A1 (en) |
CN (1) | CN117222326A (en) |
AU (1) | AU2022264845A1 (en) |
BR (1) | BR112023022096A2 (en) |
MX (1) | MX2023012843A (en) |
WO (1) | WO2022229411A1 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5186964A (en) | 1990-09-04 | 1993-02-16 | Applied Food Biotechnology, Inc. | Flavor composition for pet food |
US6254920B1 (en) | 1998-11-24 | 2001-07-03 | Ralston Purina Company | Methods and compositions for enhancing palatability of pet food |
FR2831769B1 (en) * | 2001-11-07 | 2004-07-30 | Diana Ingredients | APPEARANCE FACTOR AND TASTEFAST |
US20050037108A1 (en) | 2003-08-14 | 2005-02-17 | Charles Lin | Methods and compositions for enhancing palatability of animal feed using tetrapotassium pyrophosphate |
TW200744473A (en) * | 2006-04-19 | 2007-12-16 | Specialites Pet Food | Use of inorganic phosphate compounds as palatability enhancers of flavours generated by thermal reactions in wet pet foodstuffs |
US20140227386A1 (en) * | 2011-07-12 | 2014-08-14 | Specialites Pet Food | Palatability enhancers comprising free amino acids for use in pet foods |
AU2014394376B2 (en) * | 2014-05-15 | 2019-05-23 | Specialites Pet Food | Palatability enhancers comprising amino reactants and carbonyl compounds for use in cat food |
-
2022
- 2022-04-29 WO PCT/EP2022/061531 patent/WO2022229411A1/en active Application Filing
- 2022-04-29 BR BR112023022096A patent/BR112023022096A2/en unknown
- 2022-04-29 EP EP22727037.8A patent/EP4329512A1/en active Pending
- 2022-04-29 CN CN202280031585.6A patent/CN117222326A/en active Pending
- 2022-04-29 US US18/288,766 patent/US20240206498A1/en active Pending
- 2022-04-29 AU AU2022264845A patent/AU2022264845A1/en active Pending
- 2022-04-29 MX MX2023012843A patent/MX2023012843A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20240206498A1 (en) | 2024-06-27 |
EP4329512A1 (en) | 2024-03-06 |
WO2022229411A1 (en) | 2022-11-03 |
MX2023012843A (en) | 2023-11-13 |
AU2022264845A1 (en) | 2023-11-02 |
BR112023022096A2 (en) | 2023-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2012320643B2 (en) | Animal digests having enhanced palatability for use in pet food | |
EP2731449B9 (en) | Palatability enhancers comprising free amino acids for use in pet foods | |
EP3154368B1 (en) | Palatability enhancers comprising amino reactants and carbonyl compounds for use in cat food | |
EP2895007B1 (en) | Use of fat compositions for sustaining an enhanced palatability of pet food over time | |
CN105848493B (en) | Palatability enhancers for pet food, methods of making and uses thereof | |
JP2020501503A (en) | Compositions and methods for modulating phosphorus or enzymes in companion animals | |
JP2020103315A (en) | Palatability enhancers comprising amino reactants and carbonyl compounds for use in cat food | |
CN117222326A (en) | Novel palatability enhancing compositions | |
EP3638051A1 (en) | Vegetarian dog palatability-enhancers | |
US20240122205A1 (en) | Method for producing protein material | |
CN111372465A (en) | Pork skin derived emulsions for use in palatability enhancers | |
Lovell | Bioavailability of Nutrients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |